Share on StockTwits

CAS Medical Systems (NASDAQ:CASM) CEO Thomas M. Patton acquired 1,500 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, September 2nd. The shares were purchased at an average cost of $1.48 per share, with a total value of $2,220.00. Following the purchase, the chief executive officer now directly owns 551,677 shares in the company, valued at approximately $816,482. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Shares of CAS Medical Systems (NASDAQ:CASM) remained flat at $1.52 during during mid-day trading trading on Wednesday. The stock had a trading volume of 10,749 shares. CAS Medical Systems has a one year low of $1.211 and a one year high of $2.50. The stock’s 50-day moving average is $1.6 and its 200-day moving average is $2.01. The company’s market cap is $29.3 million.

CAS Medical Systems (NASDAQ:CASM) last announced its earnings results on Wednesday, August 6th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by $0.02. The company had revenue of $5.80 million for the quarter, compared to the consensus estimate of $5.00 million. On average, analysts predict that CAS Medical Systems will post $-0.48 earnings per share for the current fiscal year.

CAS Medical Systems, Inc (NASDAQ:CASM) is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products that is vital to patient care.

Receive News & Ratings for CAS Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems and related companies with Analyst Ratings Network's FREE daily email newsletter.